The COVID-19 pandemic opened the world’s eyes to the clinical trial process—and the importance of investing in research and development to get new prescription drugs to patients. And while the world is grateful for the speed with which the biopharmaceutical industry has developed COVID-19 vaccines…

If there’s a silver lining to the past year, it’s that we’ve learned a lot about how to accelerate innovation and get breakthroughs to patients, even in the most trying times. On January 11, 2021, BIO President and CEO Dr. Michelle McMurry-Heath joined global experts during the WuXi Global Forum…

If there’s a silver lining to the past year, it’s that we’ve learned a lot about how to accelerate innovation and get breakthroughs to patients, even in the most trying times. On January 11, 2021, BIO President and CEO Dr. Michelle McMurry-Heath joined global experts during the WuXi Global Forum…

This week is “Made in America Week.” According to the president, this is a time to pay special tribute to U.S. innovators, builders, entrepreneurs, and “all those who work with their hands every day to make America great.” We certainly have a lot to celebrate! As Under Secretary of Commerce for…

As BIO Digital kicks off today, we continue our BIO: Beyond Imagination series featuring the technology and scientific advancements of BIO member companies. Our newest post features SAB Biotherapeutics and its innovative approach for a potential COVID-19 treatment. Don’t miss SAB’s President and…

Our series, Biotechnology: Beyond Imagination, highlights the technology and scientific advancements of BIO Digital participating companies and BIO member companies. Our next feature looks at Alnylam Pharmaceuticals, a biotechnology company working on treatments for diseases that were once thought…

As we count down to BIO Digital, our BIO: Beyond Imagination series highlights the technology and scientific advancements of BIO Digital participating companies and BIO member companies. Today’s feature is Sanofi and its work to develop a potential vaccine for COVID-19. Beyond Imagination Member…

Our next post in the Biotechnology: Beyond Imagination series highlights MaxCyte and the cell therapy technology the company has developed for researchers to accelerate, streamline and improve the drug development process. Beyond Imagination Member Spotlight: MaxCyte About half of the 300 million…

We highlight the technology and scientific advancements of BIO Digital participating companies and BIO member companies in our Biotechnology: Beyond Imagination series. Our next feature focuses on Sangamo Therapeutics and its work with gene therapy for a potential treatment for Alzheimer’s patients…

This is the second post in our series, Biotechnology: Beyond Imagination, which highlights the technology and scientific advancements of BIO Digital participating companies and BIO member companies. Today’s feature focuses on INOVIO and its work to find a vaccine for COVID-19. Beyond Imagination…